156 related articles for article (PubMed ID: 33255252)
1. Platinum(II) Complexes with Bulky Disubstitute Triazolopyrimidines as Promising Materials for Anticancer Agents.
Łakomska I; Śmiłowicz D; Jakubowski M; Sitkowski J; Wojtczak A
Materials (Basel); 2020 Nov; 13(23):. PubMed ID: 33255252
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
Łakomska I; Hoffmann K; Wojtczak A; Sitkowski J; Maj E; Wietrzyk J
J Inorg Biochem; 2014 Dec; 141():188-197. PubMed ID: 25277461
[TBL] [Abstract][Full Text] [Related]
3. Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.
Hoffmann K; Wiśniewska J; Wojtczak A; Sitkowski J; Denslow A; Wietrzyk J; Jakubowski M; Łakomska I
J Inorg Biochem; 2017 Jul; 172():34-45. PubMed ID: 28477537
[TBL] [Abstract][Full Text] [Related]
4. Factors Affecting the Stability of Platinum(II) Complexes with 1,2,4-Triazolo[1,5-
Jakubowski M; Łakomska I; Kaszuba A; Wojtczak A; Sitkowski J; Jarzęcki AA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409016
[TBL] [Abstract][Full Text] [Related]
5. Structure-cytotoxicity relationship for different types of mononuclear platinum(II) complexes with 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine.
Łakomska I; Fandzloch M; Muzioł T; Sitkowski J; Wietrzyk J
J Inorg Biochem; 2012 Oct; 115():100-5. PubMed ID: 22926029
[TBL] [Abstract][Full Text] [Related]
6. Multinuclear NMR spectroscopy and antitumor activity of novel platinum(II) complexes with 5,7-disubstituted-1,2,4-triazolo[1,5-a]pyrimidines.
Łakomska I; Szłyk E; Sitkowski J; Kozerski L; Wietrzyk J; Pełczyńska M; Nasulewicz A; Opolski A
J Inorg Biochem; 2004 Jan; 98(1):167-72. PubMed ID: 14659646
[TBL] [Abstract][Full Text] [Related]
7. First dinuclear rhodium(II) complexes with triazolopyrimidines and the prospect of their potential biological use.
Fandzloch M; Augustyniak AW; Dobrzańska L; Jędrzejewski T; Sitkowski J; Wypij M; Golińska P
J Inorg Biochem; 2020 Sep; 210():111072. PubMed ID: 32563102
[TBL] [Abstract][Full Text] [Related]
8. Platinum(II) complexes with 5,7-disubstituted-1,2,4-triazolo [1,5-a]pyrimidines: spectroscopical characterization and cytotoxic activity in vitro.
Łakomska I; Fandzloch M; Popławska B; Sitkowski J
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Jun; 91():126-9. PubMed ID: 22366623
[TBL] [Abstract][Full Text] [Related]
9. Nanoencapsulation of a ruthenium(ii) complex with triazolopyrimidine in liposomes as a tool for improving its anticancer activity against melanoma cell lines.
Fandzloch M; Jaromin A; Zaremba-Czogalla M; Wojtczak A; Lewińska A; Sitkowski J; Wiśniewska J; Łakomska I; Gubernator J
Dalton Trans; 2020 Jan; 49(4):1207-1219. PubMed ID: 31903475
[TBL] [Abstract][Full Text] [Related]
10. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
[TBL] [Abstract][Full Text] [Related]
11. Mono- and dinuclear platinum(II) compounds with 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine. Structure, cytotoxic activity and reaction with 5'-GMP.
Łakomska I; Kooijman H; Spek AL; Shen WZ; Reedijk J
Dalton Trans; 2009 Dec; (48):10736-41. PubMed ID: 20023903
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
14. Tuning the anticancer properties of Pt(ii) complexes
Al-Rashdi KS; Babgi BA; Ali EMM; Davaasuren B; Jedidi A; Emwas AM; Alrayyani MA; Jaremko M; Humphrey MG; Hussien MA
RSC Adv; 2022 Sep; 12(42):27582-27595. PubMed ID: 36276022
[TBL] [Abstract][Full Text] [Related]
15. Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity.
Bratsos I; Serli B; Zangrando E; Katsaros N; Alessio E
Inorg Chem; 2007 Feb; 46(3):975-92. PubMed ID: 17257042
[TBL] [Abstract][Full Text] [Related]
16. Potentiating effect of UVA irradiation on anticancer activity of Carboplatin derivatives involving 7-azaindoles.
Štarha P; Trávníček Z; Dvořák Z; Radošová-Muchová T; Prachařová J; Vančo J; Kašpárková J
PLoS One; 2015; 10(4):e0123595. PubMed ID: 25875850
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.
Łakomska I; Fandzloch M; Muzioł T; Lis T; Jezierska J
Dalton Trans; 2013 May; 42(17):6219-26. PubMed ID: 23328694
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of [1,2-bis(4-fluorophenyl)ethylenediamine][dicarboxylato]platinum(II) complexes.
Gust R; Krauser R; Schmid B; Schönenberger H
Arch Pharm (Weinheim); 1998 Jan; 331(1):27-35. PubMed ID: 9507699
[TBL] [Abstract][Full Text] [Related]
19. Diastereomerically pure platinum(II) complexes as antitumoral agents.: The influence of the mode of binding {(N), (N,O)- or (C,N)}- of (1S,2R)[(η5-C5H5)Fe{(η5-C5H4)CHNCH(Me)CH(OH)C6H5}] and the arrangement of the auxiliary ligands.
Talancón D; López C; Font-Bardía M; Calvet T; Quirante J; Calvis C; Messeguer R; Cortés R; Cascante M; Baldomà L; Badia J
J Inorg Biochem; 2013 Jan; 118():1-12. PubMed ID: 23123334
[TBL] [Abstract][Full Text] [Related]
20. Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line.
Mauldin SK; Husain I; Sancar A; Chaney SG
Cancer Res; 1986 Jun; 46(6):2876-82. PubMed ID: 3698013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
